Prime Movers LAB

,

Firm Size

• Assets Under Management (AUM):$1.2 Billion
• Number of Funds:31
• Employees:
• Firm Type:Venture Capital
• Focus Areas: Software & Technology
  Manufacturing
  Energy
  

Description

PRIME MOVERS LAB LLC is a venture capital firm that focuses on investing in early-stage companies operating in the energy, transportation, and manufacturing sectors. Founded in 2018, the firm aims to support visionary entrepreneurs who are developing innovative solutions to address pressing global challenges, primarily focused on sustainability and the reduction of CO2 emissions. The company identifies and invests in startups that have the potential to become market leaders and disrupt traditional industries. PRIME MOVERS LAB provides not only capital but also strategic guidance and access to a network of industry experts to help the portfolio companies scale their operations and achieve success. With a team of experienced professionals, PRIME MOVERS LAB is dedicated to supporting entrepreneurs who are committed to making a positive impact on the environment and creating a more sustainable future. Their investment thesis is rooted in the belief that breakthrough technologies and innovations can help solve complex global problems and drive positive change. Overall, PRIME MOVERS LAB’s focus on investing in early-stage companies working on innovative solutions in the energy, transportation, and manufacturing sectors demonstrates their commitment to supporting and accelerating the development of transformative technologies that can have a significant impact on the world.

Latest News

Powered by

Oct 24, 2023: LyGenesis Raises $19M in Series A-2 Funding Led by Prime Movers Lab
LyGenesis, a clinical-stage biotechnology company developing cell therapies for patients with end stage liver disease, type 1 diabetes, end stage renal disease, and aging announced it has raised more than $19M in a Series A-2 financing round led by Prime Movers Lab, investors in breakthrough scientific startups, with follow-on funding from Juvenescence. This funding round will enable LyGenesis to complete its Phase 2a clinical trial (ClinicalTrials.gov Identifier: NCT04496479 ) and advance its pipeline of cell therapies.

Jul 26, 2023: Prime Movers Lab Raises $245 Million Early-Stage Fund to Advance Breakthrough Science Startups
Prime Movers Lab, a venture capital firm focused on investments in breakthrough scientific startups working to revolutionize the world's most important industries and transform billions of lives, raised $245 million for its third early-stage fund (fourth overall fund). The fund brings the venture capital firm's total assets under management to more than $1.2 billion .

Jun 22, 2023: Focused Energy Raises $82 Million in Funding to Advance Laser-Based Nuclear Fusion
 Focused Energy, a laser-based fusion startup dedicated to developing fusion as a means of generating clean alternative energy, raised an additional $11 million in Series A funding, bringing their total funding to $82 million . The round was led by Prime Movers Lab, and previous investors VCP Capital and Tony Florence joined the round as well.

May 18, 2023: Paradromics Raises $33 Million in Funding, Achieves Breakthrough Medical Device Designation from FDA
Paradromics Inc., the leading developer of high data-rate brain-computer interfaces (BCI), today announced a $33 million Series A funding round led by Prime Movers Lab. Additional investors include Westcott Investment Group, Dolby Family Ventures, and Green Sands Equity. The new funding will help Paradromics launch its first-in-human clinical trial for the Connexus ® Direct Data Interface (DDI).